EFFECTS OF ACTIVE/PASSIVE SMOKING EXPOSURE IN PATIENTS WITH COPD

Objectives: Smoke exposure of COPD (Chronic Obstructive Pulmonary Disease) patients increases the frequency of exacerbations and affects the quality of life. However, most patients still continue to active/passive smoking exposure after being diagnosed with COPD. In this study, the effects of active/passive smoking exposure on symptoms exacerbation/pulmonary functions in COPD patients were investigated. Materials and Methods: Totally 151 COPD patients were included in the study. Patient data on active/passive smoking exposure and exacerbation frequency, and COPD Assessment Test (CAT), modified Medical Research Council dyspnea scale (m-MRC), and pulmonary function tests (PFT) were recorded. As well as active smoking exposure, these parameters were especially evaluated in ex-smoker COPD patients according to passive smoking exposure. The data were evaluated in SPSS 22.0 program; X2 and student t-tests were applied. Results: Active/passive exposure was determined (26.49% and 43.05%, respectively). Total cigarette consumption was 1.5 times higher in men, and passive smoking exposure (69.56%) was higher in women. In addition, it was determined that the m-MRC score increased statistically significantly as exposure to passive cigarettes increased. It was observed that the number of exacerbations increased in ex-smoker COPD patients with passive exposure. Another finding in the study; was determined that the increase in each standard deviation in cigarette consumption caused a 19% decrease in pulmonary function capacity and an increase in m-MRC, CAT scores. Conclusion: Active/passive smoking exposure was detected in most COPD patients. It was determined that continuous smoking exposure in patients caused an increase in the number of exacerbations and a deterioration in the quality of life. Therefore, it is necessary to increase awareness of passive smoking exposure in the management of COPD patients.

PDF

___

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. 2020; https://goldcopd.org › 2021. (Accessed: 30.08.2021).
2. World Health Organization. Chronic obstructive pulmonary disease (COPD) [Internet]. 2020; https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). (Accessed: 30.06.2021).
3. De Ramon Fernandez A, Ruiz Fernandez D, Marcos-Jorquera D, Gilart Iglesias V. Support System for Early Diagnosis of Chronic Obstructive Pulmonary Disease Based on the Service-Oriented Architecture Paradigm and Business Process Management Strategy: Development and Usability Survey Among Patients and Health Care Providers. J Med Internet Res. 2020;22(3):e17161 (doi:10.2196/17161).
4. Miravitlles M, Soriano JB, Garcia-Rio F et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64(10):863–8 (doi:10.1136/thx.2009.115725).
5. Karadogan D, Önal Ö, Sahin DS, Kanbay Y. Factors associated with current smoking in COPD patients: A cross-sectional study from the Eastern Black Sea region of Turkey. Tob Induc Dis 2018;16:22 (doi: 10.18332/tid/90665).
6. Barnes PJ. GOLD 2017. A New Report. Chest 2017;151(2):245–6 (doi: 10.1016/j.chest.2016.11.042).
7. Vogelmeier CF, Criner GJ, Martinez FJ et al. A. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report. Respirology 2017;22(3):575-601 (doi:org/10.1111/resp.13012).
8. Putcha N, Barr RG, Han MK et al. Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort. Thorax 2016;71: 411-20 (doi: 10.1136/thoraxjnl-2015-207487).
9. Slowik N, Ma S, He J. The effect of secondhand smoke exposure on markers of elastin degradation. Chest 2011;140: 946-53 (doi: 10.1378/chest.10-2298).
10. Eisner MD. Secondhand smoke and obstructive lung disease: a causal effect? Am J Respir Crit Care Med 2009;179:973-4 (doi:10.1164/rccm.200903-0320ED).
11. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005;4(1):7 (doi:10.1186/1476-069X-4-7).
12. Yin P, Jiang CQ, Cheng KK et al. Passive smoking exposure and risk of COPD among adults in China: The Guangzhou Biobank Cohort Study. Lancet 2007;370:7517 (doi:10.1016/S0140-6736(0761378-6).
13. Küçük FÇU. Secondhand and Thirdhand Tobacco Smoke: Current Assessments. Journal Of Continuing Medical Education 2019;28: 2-6 (http://www.ssuk.org.tr/savefiles/OzelSayi.pdf).
14. National Cancer Institute Definition of Pack Year [Internet]. (2020); http://www.cancer.gov/Templates/db_alpha.aspx? (Accessed: 24.11.2020).
15. Perez T, Burgel PR, Paillasseur JL et al. Modified Medical Research Council scale vs baseline dyspnea index to evaluate dyspnea in chronic obstructive pulmonary disease. International Journal of COPD 2015;10:1663-72 (doi:10.2147/COPD.S82408).
16. Nascimento OA, Camelier A, Rosa FW, Menezes AM, Perez-Padilla R, Jardim JR. Latin American project for the investigation of obstructive lung disease (PLATINO group chronic obstructive pulmonary disease is underdiagnosed and undertreated in Sao Paulo (Brazil: Results of the PLATINO study. Braz J Med Biol Res 2007;40(7):887-95 (doi: org/10.1590/S0100-879X2006005000133).
17. Viejo-Banuelos JL, Pueyo-Bastida A, Fueyo-Rodriguez A. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project. Respir Med 2006;100(12):2137-43 (doi: 10.1016/j.rmed.2006.03.043).
18. Wagena EJ, van der Meer RM, Ostelo RJ, Jacobs JE, van Schayck CP. The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respir Med 2004; 98:805-15 (doi: 10.1016/j.rmed.2004.06.001).
19. Kırkıl G, Deveci F, Turgut T, Muz MH, Türkoğlu S. Factors Related with Duration of Hospital Stay in Patients with COPD. Fırat Med J 2013;18(3):171-5.
20. Jimenez-Ruiz CA, Masa F, Miravitlles M et al. IBERPOC Study Investigators. Smoking characteristics. Differences in attitudes and dependence between healthy smokers ans smokers with COPD. Chest 2001;119:1365-70 (doi: 10.1378/chest.119.5.1365).
21. Turan O, Turan PA, Mirici A. Factors that may affect FEV1 Change of COPD patients in one-year period. Medical Research Reports 2020;3(1):11-5.
22. Rabe KF, Hurd S, Anzueto A et al. Global initiative for chronic obstructive lung disease. Am J Respir Crit Care Med 2007;176: 532-5 (doi: 10.1164/rccm.200703-456SO).
23. Mirici A. COPD (Chronic Obstructive Pulmonary Disease. Chest Diseases Part 3: Obstructive Pulmonary Diseases Airway Diseases [Internet]. 2020; https://www.solunum.org.tr › Tusad Data › Book › 1. 107202017054-bolum03. Turkish. (Accessed: 24.07.2021).
24. Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: The Lung Health Study. Am J Med 1999;106:410-16 (doi: 10.1016/s0002-9343(9900056-x).
25. Jimenez-Ruiz CA, Pascual Liedó JF, Cícero Guerrero A, Cristóbal Fernández M, Mayayo Ulibarri M. Analysis of quality of life in patients with Chronic Obstructive Pulmonary Disorder (COPD who give up smoking. Semergen 2018;44(5):310-15 (doi: 10.1016/j.semerg.2017.08.003).
26. Cheruvu VK, Odhambo LA, Mowls DS, Zullo MD, Gudna AT. Health-related quality of life in current smokers with COPD: factors associated with current smoking and new insights into sex differences. Int J Chronic Obstructive Pulmonary Dis 2016;11:2211-19 (doi: 10.2147/copd.s 106207).
27. Ko FW, Chan KP, Hui DS et al. Acute exacerbation of COPD. Respirology 2016;21(7):1152-65 (doi: 10.1111/resp.12780).
28. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. National Center for Chronic Disease Prevention and Health Promotion (US Office on Smoking and Health [Internet]. 2014; https://www.ncbi.nlm.nih.gov. (Accessed: 24.11.2020).
29. Örnek T, Tor M, Kıran S, Atalay F. Prevalence of chronic obstructive pulmonary disease in Zonguldak province of Turkey. Tuberk Toraks 2015;63(3):170-177 (doi: 10.5578/tt.9582).
30. Fildan AP, Mihaltan FD, Rajnoveanu RM, Ulmeanu R. Pulmonary Effects of Passive Smoking Among Adults, Smoking Prevention and Cessation [Internet]. 2018; https://www.intechopen.com /books/smoking-prevention-and-cessation/pulmonary-effects-of-passive-smoking-among-adults. (Accessed: 05.05.2021).